Has the A2 Milk share price growth capped out in 2019?

The A2 Milk Company Ltd (ASX: A2M) share price has surged a whopping 2,755% higher since its April 2015 IPO – but is the share price growth coming to an end for a2 Milk?

The A2 Milk Company Ltd (ASX: A2M) share price has surged a whopping 2,755% higher since its April 2015 IPO – but is the share price growth train coming to an end for a2 Milk?

a woman

What has caused a2 Milk's share price to surge higher?

The a2 Milk share price has managed to climb 53.7% higher so far this year as the S&P/ASX 200 (INDEXASX: XJO) index enjoyed its best start to the year since 1991.

The company remains in the box seat amongst the New Zealand-based infant and baby formula companies and has managed to outpace its Aussie rivals including Bellamy's Australia Ltd (ASX: BAL) and Wattle Health Australia Ltd (ASX: WHA).

a2 Milk's equity has been a top performing growth stock over the last 4 years or so as it has cleared regulatory hurdles and expanded its channels both at home and abroad.

One key that unlocked significant capital gains for a2 Milk was its regulatory approval in China to capture large swathes of the lucrative infant and baby formula market, as well as its mainstream dairy products in Aussie supermarkets.

a2 Milk has also been very clever in marketing the a2 advantage in its milk, which has seen sales soar. The company's share price has kept pace with sales, soaring to its current $16.00 valuation.

Why the growth train may be slowing this year

While a2 has delivered outstanding capital gains for its initial investors, I think the potential upside for the stock is limited in the second half of the year.

There is increasing competition in the market and the likes of Bellamy's and Wattle Health have been pressuring margins and signing big contracts as they capture a larger chunk of the market.

While a2 Milk remains the incumbent, recent changes in the Chinese regulatory environment have put pressure on foreign suppliers (i.e. from Australia and New Zealand) to await approval from China's food and drug administrators.

I think some of the smaller players such as Wattle Health or Bubs Australia Ltd (ASX: BUB) have significant upside and could deliver stronger capital gains over the next 5 years or so.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Bellamy's Australia and BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man smiling ahead while working on his MacBook.
Growth Shares

Could $10,000 invested in these 2 ASX shares become $50,000 by 2035?

Both companies are operating in growing markets, and I think their long-term potential could be huge.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Growth Shares

Could these 3 ASX shares grow into $100 billion companies by 2036?

I wouldn't rule out any of these three companies reaching this milestone, although I'd be much more confident backing one…

Read more »

Two men sit side by side on a couch with video game controls in their hands and expressive looks on their faces.
Growth Shares

3 ASX growth shares almost as exciting as the GTA 6 release

It is a great time to be a gamer. But are these shares just as exciting?

Read more »

Happy young couple riding a motorbike together.
Growth Shares

3 ASX shares I think could be worth twice as much in 5 years

These shares appear well-placed for growth over the next half-decade.

Read more »

Happy businessman fist pumping while looking at a tablet.
Growth Shares

Why WiseTech and these ASX growth shares make my shortlist for 2027

There are reasons to be positive on these growing companies.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Growth Shares

Could this ASX 200 share turn $10,000 into $20,000 by 2030?

The company already has an impressive global presence, but I think there's still plenty of room to grow.

Read more »

Two shop workers smiling and looking at a laptop surrounded by plants.
Growth Shares

The ASX's next great growth stock? I've narrowed my shortlist to two

These companies have already made impressive progress, but I think there's still a lot more they could achieve.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Multiple brokers are excited about these ideas.

Read more »